GSK: Result Summaries: Compounds

Result Summaries: GSK159802

Result Summaries for GSK159802
GSK Study ID	Phase	Title	Summary (Download)
100819	Phase 1	A randomised, double-blind, three-way crossover study to investigate the effects of nebulised sterile water for injection on beta-agonist induced bronchodilation in healthy male and female volunteers. (0 citation(s))
B2F104300	Phase 1	A randomised, double-blind, placebo controlled study to examine the safety, tolerability, pharmacodynamics and pharmacokinetics of single inhaled dry powder doses of GSK159802 in healthy male subjects and asthmatics (0 citation(s))